VANCOUVER, British Columbia, March 09, 2018 -- Glenbriar Technologies Inc. (CSE:GTI) (the “Company”) announces that further to its press release dated March 1, 2018, Uniserve Communications Corporation (“Uniserve”) has completed the sale (the “Transaction”) of all of its shares of the Company (representing approximately 86% of the Company’s outstanding shares), to several arm’s length purchasers, in a private, off-market transaction. The Company has been advised that the purchasers acted independently from each other and that no purchaser owns more than 10% of the outstanding shares of the Company. Upon completion of the Transaction, Mr. Walter Schultz resigned from the Company’s board of directors. The Company wishes to thank Walter for his contributions to the board during this transition period. The Company also wishes to announce that Mr. Douglas Taylor has been appointed to the board.
Mr. Taylor has extensive experience in managing projects, facilities and services in the public sector. His work included community engagement, strategic planning, business planning and implementation for a wide range of recreation facilities and services. Implementation included budgeting, financial planning, human resources, and project management.
For further information call:
Hashim Mitha, CEO, Glenbriar Technologies Inc.
604-395-3900
[email protected]
The CSE has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.
This news release may contain forward-looking statements. These forward-looking statements do not guarantee future events or performance and should not be relied upon. Actual outcomes may differ materially due to any number of factors and uncertainties, many of which are beyond Glenbriar’s control. Some of these risks and uncertainties may be described in Glenbriar’s corporate filings (posted at www.sedar.com. Glenbriar has no intention or obligation to update or revise any forward-looking statements due to new information or events.


Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Anta Sports Expands Global Footprint With Strategic Puma Stake 



